Syngeneic Bone Marrow Mononuclear Cells Improve Pulmonary Arterial Hypertension Through Vascular Endothelial Growth Factor Upregulation

Annals of Thoracic Surgery

Volumn 88, Issue 2, 2009, Pages 418-424

  Yoshida, Homare ^a   Kitaichi, Takashi ^a   Urata, Masahisa ^a   Kurobe, Hirotsugu ^a   Kanbara, Tamotsu ^a   Motoki, Tatsuo ^a   Kitagawa, Tetsuya ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCROTALINE; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART VENTRICLE SEPTUM; HEART WEIGHT; ISOGRAFT; LUNG PARENCHYMA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENE THERAPY; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MONOCROTALINE; MONOCYTES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRANSPLANTATION, ISOGENEIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 67650741386     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.04.105     Document Type: Article

References (27)

1. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Hayashida K., Fujita J., Miyake Y., et al. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Chest 127 (2005) 1793-1798
3. Zhao Y.D., Courtman D.W., Deng Y., Kugathasan L., Zhang Q., and Stewart D.J. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96 (2005) 442-450
4. Campbell A.I., Zhao Y., Sandhu R., and Stewart D.J. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104 (2001) 2242-2248
5. Losordo D.W., and Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II: cell-based therapies. Circulation 109 (2004) 2692-2697
6. Raoul W., Wanger-Ballon O., Saber G., et al. Effects of bone marrow-derived cells on monocrotaline and hypoxia-induced pulmonary hypertension in mice. Respir Res 8 (2007) 8-16
7. Dor Y., Porat R., and Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am J Physiol 280 (2001) C1367-C1374
8. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
9. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
10. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
11. Sahara M., Sata M., Morita T., Nakamura K., Hirata Y., and Nagai R. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 115 (2007) 509-517
12. Pascaud M.A., Griscelli F., Raoul W., et al. Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice. Am J Respir Cell Mol Biol 29 (2003) 449-457
13. Takahashi M., Nakamura T., Toba T., Kajiwara N., Kato H., and Shimizu Y. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng 10 (2004) 771-779
14. Sun L., Tran N., Tang F., et al. Synthesis and biological evaluation of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem 41 (1998) 2588-2603
15. Zhang S., Guo J., Zhang P., et al. Long-term effects of bone marrow mononuclear cell transplantation on left ventricular function and remodeling in rats. Life Sci 74 (2004) 2853-2864
16. Kotton D.N., Fabian A.J., and Mulligan R.C. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 33 (2005) 328-334
17. Voswinckel R., Ziegelhoeffer T., Heil M., et al. Circulating vascular progenitor cells do not contribute to compensatory lung growth. Circ Res 93 (2003) 372-379
18. O'Neill T.J., Wamhoff B.R., Owens G.K., and Skalak T.C. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 97 (2005) 1027-1035
19. Tanaka K., Sata M., Hirata Y., et al. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 93 (2003) 780-790
20. Klein M., Schermuly R.T., and Ellinghaus P. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. Circulation 118 (2008) 2081-2090
21. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64 (2002) 993-998
22. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
23. Holash J., Wiegand S.J., and Yancopoulos G.D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18 (1999) 5356-5362
24. Holash J., Maisonpierre P.C., Compton D., et al. Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF. Science 284 (1999) 1994-1998
25. Tateno K., Minamino T., Toko H., et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 98 (2006) 1194-1202
26. Perlman H., Maillard L., Krasinski K., et al. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95 (1997) 981-987
27. Caplan A.I. Why are MSCs therapeutic?. New data: new insight. J Pathol 217 (2009) 318-324